Klinefelter syndrome (KS) was first described by Harry F. Klinefelter in 1942 as an endocrine disorder characterized by small firm testes, gynecomastia, hypogonadism, and abnormally elevated concentrations of follicle-stimulating hormone (FSH) [1]. The gene discussed is BRD2; the disease is Gynecomastia.